Nice post ZOELLERSomething interesting to think about when you...

Nice post ZOELLER

Something interesting to think about when you look at those potential figures.

Using AHZ and their HSV Vaccine as an example

For ADO - Bioseparations potential revenue is massive - But it is not like a 10 year trial process to maybe achieve success potentially I dont know maybe a 10% success rate to market?

Mixngo is already proven in Bioseparations and what they can do

Those that want to try and value ADO and dont understand Bioseparations market will look back in time when the shareprice is traded in the multiple dollar range and wonder why (This is obviously not short term ramping but a long term investor looking to discount future earnings back to a NPV)

Add to this Cleantech opportunity

This is not a pipe dream - It is a proven working commercial product